TPWA
STOK icon

TRUE Private Wealth Advisors’s Stoke Therapeutics STOK Stock Holding History

TRUE Private Wealth Advisors’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-400
Closed -$13K – 762
2020
Q3 		$13K Hold
400
– – ﹤0.01% 464
2020
Q2 		$9K Hold
400
– – ﹤0.01% 510
2020
Q1 		$9K Buy
+400
New +$9.88K ﹤0.01% 472

Other funds holding STOK

ALSV
ATP Life Science Ventures New York $898M AUM 84.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

TRUE Private Wealth Advisors's STOK Position: Q4 2020 in Review

TRUE Private Wealth Advisors sold out of Stoke Therapeutics (STOK) in Q4 2020, closing a stake of 400 shares — an estimated $13K sold.

TRUE Private Wealth Advisors first reported a position in STOK in Q1 2020 and held it in 3 quarters. The position peaked at $13K in Q3 2020. 93 funds tracked by Wall St. Rank hold STOK as of Q4 2020.

  • TRUE Private Wealth Advisors reported no remaining Stoke Therapeutics position as of Q4 2020 after selling out during the quarter.
  • TRUE Private Wealth Advisors sold 400 Stoke Therapeutics shares in Q4 2020, an estimated $13K.
  • TRUE Private Wealth Advisors first reported a position in Stoke Therapeutics in Q1 2020 and held it in 3 quarters.
  • TRUE Private Wealth Advisors's Stoke Therapeutics position peaked at $13K in Q3 2020.
  • 93 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q4 2020.

Based on TRUE Private Wealth Advisors's 13F filing for Q4 2020, filed 11 Jan 2021.